| Dr Sanjay Vyas, DO | |
|
701 E County Line Rd, Suite 101, Greenwood, IN 46143-1070 | |
| (317) 883-4736 | |
| (317) 885-2869 |
| Full Name | Dr Sanjay Vyas |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 701 E County Line Rd, Greenwood, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295708766 | NPI | - | NPPES |
| 200289430 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 02001940A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan Vns Home Care, Inc | Beech grove, IN | Home health agency |
| Franciscan Health Indianapolis | Indianapolis, IN | Hospital |
| Indiana University Health | Indianapolis, IN | Hospital |
| Franciscan Health Mooresville | Mooresville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana Internal Medicine Consultants Llc | 7911899489 | 41 |
| St Francis Medical Group Llc | 7012067697 | 112 |
News Archive
To date, there have been relatively few cases of neonates with COVID-19, and there is limited knowledge of neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, recent studies have suggested an increased risk of severe COVID-19 in infants compared to older children, which is based on data that shows an increased rate of hospitalization among infants.
Teva Pharmaceutical Industries Ltd., today announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).
A new study conducted in the Children's Hospital Of Philadelphia (CHOP) reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B.
A new study describing the outcome of a clinical trial of two malaria treatment protocols involving the use of triple therapies based on artemisinin reports their high efficacy and low adverse effects.
Researchers at Yale School of Medicine have found that a compound produced by the body when dieting or fasting can block a part of the immune system involved in several inflammatory disorders such as type 2 diabetes, atherosclerosis, and Alzheimer's disease.
› Verified 4 days ago
| Entity Name | Indiana Internal Medicine Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609834357 PECOS PAC ID: 7911899489 Enrollment ID: O20040329000685 |
News Archive
To date, there have been relatively few cases of neonates with COVID-19, and there is limited knowledge of neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, recent studies have suggested an increased risk of severe COVID-19 in infants compared to older children, which is based on data that shows an increased rate of hospitalization among infants.
Teva Pharmaceutical Industries Ltd., today announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).
A new study conducted in the Children's Hospital Of Philadelphia (CHOP) reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B.
A new study describing the outcome of a clinical trial of two malaria treatment protocols involving the use of triple therapies based on artemisinin reports their high efficacy and low adverse effects.
Researchers at Yale School of Medicine have found that a compound produced by the body when dieting or fasting can block a part of the immune system involved in several inflammatory disorders such as type 2 diabetes, atherosclerosis, and Alzheimer's disease.
› Verified 4 days ago
| Entity Name | St Francis Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467693135 PECOS PAC ID: 7012067697 Enrollment ID: O20090603000310 |
News Archive
To date, there have been relatively few cases of neonates with COVID-19, and there is limited knowledge of neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, recent studies have suggested an increased risk of severe COVID-19 in infants compared to older children, which is based on data that shows an increased rate of hospitalization among infants.
Teva Pharmaceutical Industries Ltd., today announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).
A new study conducted in the Children's Hospital Of Philadelphia (CHOP) reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B.
A new study describing the outcome of a clinical trial of two malaria treatment protocols involving the use of triple therapies based on artemisinin reports their high efficacy and low adverse effects.
Researchers at Yale School of Medicine have found that a compound produced by the body when dieting or fasting can block a part of the immune system involved in several inflammatory disorders such as type 2 diabetes, atherosclerosis, and Alzheimer's disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sanjay Vyas, DO 701 E County Line Rd, Suite 101, Greenwood, IN 46143-1070 Ph: (317) 883-4736 | Dr Sanjay Vyas, DO 701 E County Line Rd, Suite 101, Greenwood, IN 46143-1070 Ph: (317) 883-4736 |
News Archive
To date, there have been relatively few cases of neonates with COVID-19, and there is limited knowledge of neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, recent studies have suggested an increased risk of severe COVID-19 in infants compared to older children, which is based on data that shows an increased rate of hospitalization among infants.
Teva Pharmaceutical Industries Ltd., today announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).
A new study conducted in the Children's Hospital Of Philadelphia (CHOP) reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B.
A new study describing the outcome of a clinical trial of two malaria treatment protocols involving the use of triple therapies based on artemisinin reports their high efficacy and low adverse effects.
Researchers at Yale School of Medicine have found that a compound produced by the body when dieting or fasting can block a part of the immune system involved in several inflammatory disorders such as type 2 diabetes, atherosclerosis, and Alzheimer's disease.
› Verified 4 days ago
Dr. Elise Rose Laroche, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 747 E County Line Rd Ste D, Greenwood, IN 46143 Phone: 317-888-9669 Fax: 317-885-7966 | |
Brittany Y. Simpson, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 533 E County Line Rd, Greenwood, IN 46143 Phone: 317-957-9050 | |
Dr. Charles L Richert, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3000 S State Road 135 Ste 220, Greenwood, IN 46143 Phone: 317-621-2290 | |
Dr. Douglas K Bullington, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3000 S State Road 135, Suite 200, Greenwood, IN 46143 Phone: 317-535-1876 Fax: 317-535-5049 | |
Shelley R Stiner, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 107 N State Road 135, Ste 103, Greenwood, IN 46142 Phone: 317-550-4510 Fax: 317-886-4550 | |
Ehab Wanas, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E County Line Rd, Suite 101, Greenwood, IN 46143 Phone: 317-885-2860 Fax: 317-885-2869 | |
Sarah Ann Beeson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3000 S State Road 135 Ste 200, Greenwood, IN 46143 Phone: 317-535-1876 |